Tradestie Institutional Equity Comparison Engine

OSRH vs IBO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IBO Overall Edge

IBO Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Impact BioMedical, Inc. (IBO) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, OSRH trades at N/M Forward P/E with -960.8% operating margin (-72.2% YoY revenue) versus IBO at N/M Forward P/E and -12621.0% operating margin (+16.7% YoY). In options structure, OSRH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IBO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IBO
OSRH N/M vs IBO N/M Fwd P/E
Growth & Margin Winner IBO
Op Margin -960.8% vs -12621.0% ยท YoY -72.2% vs +16.7%
Momentum & Technical Winner IBO
1Y -77.4% vs +862.8% ยท 52W Pos 3% vs 67%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OSRH NASDAQ
OSR Holdings, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.12
-53.4% 1D
Market Cap $8.8M
1M Return -73.1%
1Y Return -77.38%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 33.0 Fund 46.0 Flow 50.0 Mom 60.0
IBO NYSE American
Impact BioMedical, Inc.
Pharmaceutical Preparations
$4.91
-4.47% 1D
Market Cap $44.4M
1M Return +83.21%
1Y Return +862.75%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 15.0 Fund 32.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OSRH -77.38% IBO +862.75% Spread: +69.62 pp (IBO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period OSRH Revenue IBO Revenue OSRH Op. Margin IBO Op. Margin Margin Edge
FY2022 N/A $0M N/A -6808.0% IBO
FY2024 $0M N/A -331.2% N/A OSRH
FY2025 $0M $0M -631.0% -13381.2% OSRH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OSRH (2) vs IBO (7)
Institutional Metric OSRH IBO Criterion Row Winner
Market Capitalization Scale $8.8M $44.4M Larger Scale IBO
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple IBO
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -72.2% +16.7% Higher Growth IBO
Operating Margin (TTM) Profitability -960.8% -12621.0% Higher Margin OSRH
Net Profit Margin Profitability 0.0% 4247.4% Higher Margin IBO
Return on Equity (ROE) Capital Efficiency -11.3% 71.2% Higher ROE IBO
52-Week Range Position Momentum 3% ($0โ€“$1) 67% ($0โ€“$7) Stronger Trend IBO
Beta / 30D Volatility Risk Regime 0.57ฮฒ ยท 390% Vol -6.72ฮฒ ยท 120% Vol Lower Realized Risk IBO
Unified Institutional Score Composite Signal 45.0 / 100 (HOLD) 36.8 / 100 (SELL) Higher Composite OSRH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OSRH vs IBO Buy Guide
OSRH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OSRH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IBO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IBO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OSRH nor IBO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.